Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study.

Front Oncol · 2022 · PMC9019360 · PMID 35463372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approaching significancep = 1.12not a probability at all

The differences, as shown in Table 2 , were not statistically significant, although they were approaching significance for VEGFR2 (p = 1.12) and VEGFR3 (p = 1.19) receptors.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.